Cargando…
P34.02 The Inhibitory Effect of Cisplatin, Paclitaxel, and Pemetrexed on the Growth of PC9GR Cells During the COVID-19 Pandemic
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523146/ http://dx.doi.org/10.1016/j.jtho.2021.08.419 |
_version_ | 1784585236767571968 |
---|---|
author | Mohiuddin, M. Kasahara, K. |
author_facet | Mohiuddin, M. Kasahara, K. |
author_sort | Mohiuddin, M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8523146 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85231462021-10-20 P34.02 The Inhibitory Effect of Cisplatin, Paclitaxel, and Pemetrexed on the Growth of PC9GR Cells During the COVID-19 Pandemic Mohiuddin, M. Kasahara, K. J Thorac Oncol P34 Management of Lung Cancer in the Era of Covid-19 - Treatment of Lung Cancer during Covid-19 Published by Elsevier Inc. 2021-10 2021-10-18 /pmc/articles/PMC8523146/ http://dx.doi.org/10.1016/j.jtho.2021.08.419 Text en Copyright © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | P34 Management of Lung Cancer in the Era of Covid-19 - Treatment of Lung Cancer during Covid-19 Mohiuddin, M. Kasahara, K. P34.02 The Inhibitory Effect of Cisplatin, Paclitaxel, and Pemetrexed on the Growth of PC9GR Cells During the COVID-19 Pandemic |
title | P34.02 The Inhibitory Effect of Cisplatin, Paclitaxel, and Pemetrexed on the Growth of PC9GR Cells During the COVID-19 Pandemic |
title_full | P34.02 The Inhibitory Effect of Cisplatin, Paclitaxel, and Pemetrexed on the Growth of PC9GR Cells During the COVID-19 Pandemic |
title_fullStr | P34.02 The Inhibitory Effect of Cisplatin, Paclitaxel, and Pemetrexed on the Growth of PC9GR Cells During the COVID-19 Pandemic |
title_full_unstemmed | P34.02 The Inhibitory Effect of Cisplatin, Paclitaxel, and Pemetrexed on the Growth of PC9GR Cells During the COVID-19 Pandemic |
title_short | P34.02 The Inhibitory Effect of Cisplatin, Paclitaxel, and Pemetrexed on the Growth of PC9GR Cells During the COVID-19 Pandemic |
title_sort | p34.02 the inhibitory effect of cisplatin, paclitaxel, and pemetrexed on the growth of pc9gr cells during the covid-19 pandemic |
topic | P34 Management of Lung Cancer in the Era of Covid-19 - Treatment of Lung Cancer during Covid-19 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523146/ http://dx.doi.org/10.1016/j.jtho.2021.08.419 |
work_keys_str_mv | AT mohiuddinm p3402theinhibitoryeffectofcisplatinpaclitaxelandpemetrexedonthegrowthofpc9grcellsduringthecovid19pandemic AT kasaharak p3402theinhibitoryeffectofcisplatinpaclitaxelandpemetrexedonthegrowthofpc9grcellsduringthecovid19pandemic |